CoChat

Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration

Gondwe, J. S., Davidson, J. E., Deeley, S., Sills, J., Cleary, A. G. · 2005 · Rheumatology
Cited by 33

The DOI matches its Crossref record.

Abstract

Sir, Intra-articular corticosteroid injection is a widely used treatment in the management of juvenile idiopathic arthritis (JIA) that generally induces rapid resolution of synovitis [1]. Triamcinolone hexacetonide (TH) is the preferred drug, with sustained symptom relief over longer periods than triamcinolone acetonide (TA) [2–4]. However, due to recent difficulties in obtaining TH, TA was used in our unit as an alternative agent. One hundred and ninety-five children (362 joints) and 180 children (216 joints) received intra-articular TH and TA, respectively, over a 3-yr period. Visibly prominent Cushing's syndrome developed in nine (5%) of the children who had received TA. The clinical details are summarized in Table 1. Intra-articular steroid injection is safe and effective in the management of JIA in children. Excessive weight gain and cushingoid appearance have been reported in adults and children following intra-articular TA injections but not with TH [5, 6]. Huppertz and Pfuller [7] reported transient suppression of endogenous cortisol release, detected by a low morning peak value of salivary cortisol, with no adverse events noted. Adrenocortical insufficiency was not formally assessed in our patient group. We did not observe a cushingoid state with TH even when multiple joints were injected, but accept that very minor weight gain or less prominent features, such as transient flushing of the cheeks, may not have been detected by this retrospective review. The development of a cushingoid state does not appear to be related to sex, age, current therapy or the type of arthritis. Although most of the children we report had multiple intra-articular injections (up to eight joints at a time with a cumulative TA dose of up to 14.5 mg/kg), Cushing's syndrome still occurred in three children who had only one or two joints injected (cases 5, 7 and 8). In our experience this side-effect was distressing for both carers and patients, although spontaneous resolution occurred, albeit over a variable period (no greater than 5 months in any patient). The resolution of hypercortisolism has been reported elsewhere to last up to 8 months [6]. We did not collect systematic data relating to the time of resolution in our patients, but none was greater than 5 months.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kei154

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 33

Metadata

Authors
Gondwe, J. S., Davidson, J. E., Deeley, S., Sills, J., & Cleary, A. G.
Venue
Rheumatology
Published
2005-10-11
Volume
44
Issue
11
Pages
1457-1458
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W1984427728
Cited by
33
References
0
FWCI
0.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. https://app.cochat.ai/papers/10.1093/rheumatology/kei154
The paper
Gondwe, J. S., Davidson, J. E., Deeley, S., Sills, J., & Cleary, A. G. (2005). Secondary Cushing's syndrome in children with juvenile idiopathic arthritis following intra-articular triamcinolone acetonide administration. Rheumatology. https://doi.org/10.1093/rheumatology/kei154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.